Management Of Vhl Associated Pheochromocytoma/Pancreatic Lesions | Electron Kebebew, Md, Facs

Management of VHL Associated Pheochromocytoma/Pancreatic Lesions | Electron Kebebew, MD, FACS

Update on Hereditary Pheochromocytoma | Karel Pacak, MD, PhD, DSc, FACE

Current Concepts in the Management of VHL

What is Pheochromocytoma?

Pheo Para Alliance

Pheochromocytoma | Symptoms and Treatment

VHL and Other Emergent Pseudohypoxic Diseases | Fraser Ferens, PhD

Von Hippel-Lindau Disease: Clinical Update and New Drug Therapy

Breakthroughs for Physicians

Pheochromocytoma Treatment

Current Treatment Options for VHL Disease

PIV5Rights FlowRighteous Case Study - Minimum Hemodilution Subject #4

Nexus Medical LLC

Role Of Renal Ablative Therapy and Minimally Invasive Surgery in VHL Treatment | Benjamin Chung, MD

Polyomavirus Nephritis | Banff & Beyond

Arkana Laboratories

Leukamia Care and how HCPs can benefit from their work

VJHemOnc – Video Journal of Hematology & HemOnc

Investigating PIkfyve and Lysosomes as Target in VHL Diseases | Sandra Turcotte, PhD

KD033, a PDL1-1L15 bispecific molecule for the treatment of cancer

Bepirovirsen Receives FDA Fast Track Designation

Endo-lysosomal pathway proteins as potential Huntington’s disease biomarkers

Adverum Biotechnologies

Alliance for Regenerative Medicine

The role of pembrolizumab and HIF-2α inhibitors in renal carcinoma